![Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/181/1/146/F4.large.jpg)
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
![Ioannis Tsavaris erzählt vom Überfall auf seinen Juwelierladen: "Da habe ich ihn angegriffen" | Onetz Ioannis Tsavaris erzählt vom Überfall auf seinen Juwelierladen: "Da habe ich ihn angegriffen" | Onetz](https://www.onetz.de/sites/default/files/imagecache/ga-large/articlemedia/2017/08/04/742010_orig.jpg)
Ioannis Tsavaris erzählt vom Überfall auf seinen Juwelierladen: "Da habe ich ihn angegriffen" | Onetz
![PDF) Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non‑small‑cell lung cancer patients PDF) Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non‑small‑cell lung cancer patients](https://i1.rgstatic.net/publication/305694258_Distinct_patterns_of_angiogenic_factor_expression_as_a_predictive_factor_of_response_to_chemotherapy_in_stage_IIIA_non-small-cell_lung_cancer_patients/links/579cc12f08ae802facbb9569/largepreview.png)
PDF) Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non‑small‑cell lung cancer patients
The Hellenic Medical Society of New York - Dr. George Papanicolaou Awards Symposium Program Honoring Ioannis A. Zervoudakis, M.D. Thursday May 23, 2013 6-9 PM Weill Cornell Medical College Also featuring fraternization
![PDF) Properties with Potent Antitumor neu HER2/ HLA-A*0201Binding Epitope of Identification of a Novel Immunogenic PDF) Properties with Potent Antitumor neu HER2/ HLA-A*0201Binding Epitope of Identification of a Novel Immunogenic](https://i1.rgstatic.net/publication/237495612_Properties_with_Potent_Antitumor_neu_HER2_HLA-A0201Binding_Epitope_of_Identification_of_a_Novel_Immunogenic/links/004635285d2be3b79f000000/largepreview.png)
PDF) Properties with Potent Antitumor neu HER2/ HLA-A*0201Binding Epitope of Identification of a Novel Immunogenic
![PDF) Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties PDF) Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties](https://i1.rgstatic.net/publication/5288968_Identification_of_a_Novel_Immunogenic_HLA-A0201-Binding_Epitope_of_HER-2neu_with_Potent_Antitumor_Properties/links/00b49521da0610a280000000/largepreview.png)
PDF) Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties
![Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis | SpringerLink Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis | SpringerLink](https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2F1471-2407-9-264/MediaObjects/12885_2009_Article_1598_Fig1_HTML.jpg)
Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis | SpringerLink
![Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/181/1/146/F7.large.jpg)
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
![PDF) Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients PDF) Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients](https://i1.rgstatic.net/publication/46159328_Combined_treatment_with_Bevacizumab_and_standard_chemotherapy_restores_abnormal_immune_parameters_in_advanced_colorectal_cancer_patients/links/56cb73cb08ae5488f0db1529/largepreview.png)